Western democracies may lose the coronavirus propaganda war, but China certainly won’t win it.
- 74.3 Public Health
- 31.6 Financial
- 4 Fact-Based
China’s aggressive lockdowns played a key role in controlling case and death rates. However, its low score is driven by multiple factors, including the country’s minimal financial response and lack of press freedom and fact-based communications. China’s failure to report testing obscures understanding of actual COVID-19 dynamics within the country.
Despite one of the best debt-to-GDP ratios, China’s relative underinvestment in healthcare infrastructure pre-COVID—notably hospital beds—limited its capacity to rapidly respond immediately to the crisis.
- Debt/GDP ratio 50.6%
- GDP/capita $20,984
- Gini coefficient (out of 100) 38.5
- Infant mortality rate (out of 1,000 live births) 7
- Healthcare access score (out of 100) 74.2
- Hospital beds/1,000 People 29.9
Government ResponseSelect a data point for more information
(Data points represent policy level as of Jan 1.)
Public Health Directives
Strict stay-at-home orders issued on February 1st mitigated a worse spread of the virus and helped drive China’s relatively strong public health policy, though its limited emergency healthcare spending and testing policy push its score slightly lower.
- Stay at home order 3
- Public gathering restrictions 4
- School closings 3
- Public event cancellations 2
- Testing policy 3
- Emergency healthcare investments/capita $14.46
- Travel restrictions 3
- Tests/1,000 people 111.2
- Contact tracing 2
China’s stimulus package was limited and provided minimal debt relief or income support, resulting in a relatively weak score.
- Financial stimulus as share of GDP 6%
- Income support 1
- Debt forebearance 2
China’s government has promoted factually incorrect information about COVID-19 and has limited press reporting on the pandemic.
- Reliance on science/fact based information 3
- Press freedom 3
COVID-19 Status as of Jan 1
China’s early, restrictive lockdown likely contributed to it having among the lowest death and case rates in the Index, based on CCP reporting. However, China has not reported any official data on testing, and given its limited use of facts and press limitations, it is unclear how reliable these numbers are.
- Total deaths 4,782
- Death rate per 100K 3.3
- Total cases 96,023
- Cases per 100K 67
- Percent of positive tests NO DATA
|1||Apr 08||Wuhan lockdown ends||0.04|
|2||Jul 19||Urumqi (Xinjian capital) enters lockdown||0.04|
- China prepares rollout of domestically developed COVID-19 vaccine: Provinces across China are placing initial orders for China's domestically made COVID-19 vaccine, despite developers not yet disclosing the effectiveness of the vaccine or the potential side effects. China has also been taking orders from developing countries around the world for its vaccine, shipping 1.2 million doses to Indonesia at the start of December. Read More
- The UAE and Bahrain approve China's COVID-19 vaccine: China's COVID-19 vaccine was developed by the state-run company Sinopharm and has been claimed to be 86 percent effective. However, there has been a lack of clinical trials, and no peer-reviewable evidence has been released to support the effectiveness claims. Read More
- Chinese news outlets seek to change COVID-19 origin story: State media outlets have been increasingly reporting that COVID-19 originated outside of China and that the disease was brought into Wuhan through frozen food imports. Chinese scientists have also submitted a non-peer-reviewed paper for publication that claims the first COVID-19 case may have been in India. Read More
- Two Chinese cities implement transportation bans after new outbreaks detected Residents in Shijiazhuang and Xingtai in China's Henei province were banned from leaving unless absolutely necessary after a breakout of 127 new COVID-19 cases and 183 asymptomatic infections. Read More
- Critic sentenced to prison: Ren Zhiqiang was sentenced to 18 years in prison after he criticized China's poor handling of COVID-19. Read More
- Wartime Mode in Xinjiang meeting resistance: While much of China has re-opened from COVID-19 lockdowns, the 22 million residents of the Western region of Xinjiang—half of whom are Uighurs—remain under severe lockdown and surveilled by community officials and auxiliary police. Read More
- Vaccine potential faces headwinds: Chinese companies are among the leaders in the development of a COVID-19 vaccines, but may struggle to find the thousands of participants necessary for Phase III trials and will face intense scrutiny given the country's opaque regulatory system, limited disclosure of data, and previous vaccine scandals. Read More
Compared with Neighboring Countries
Per 1M 148,994
India scores just above the median, a large drop-off in recent months, keyed by substantial weakening of restrictions and worsening financial support.
Per 1M 3,342
Japan has a strong overall score, driven by its generous financial response and a reliance on facts, although its public health policy is very weak.
43.7South Korea 62,593
Per 1M 942
South Korea has a relatively strong score, brought down some by its very weak financial policy; its public health score is likely underestimated here, given the data’s limitations to adequately account for the impacts of the country’s advanced contact tracing.
Further Reading From Foreign Policy
Be the source of actionable insight.
Select one of the subscription options below to read the full Covid-19 Global Response Index. Unlock even more global intelligence with a subscription to FP Insider.
Already an FP Insider? Log In
Looking for group access? Contact us directly
Statistics and government response factors available on each country profile include:
- Debt to GDP ratio
- Infant mortality rates
- Hospital beds per 1,000 people
- Gini coefficients measuring inequality
- Health access and quality
COVID-19 Public Health Directives:
- Stay-at home orders
- School-closing policy
- Public-gathering restrictions
- Cancellation of public events
- Testing policy and rates per 1,000 people
- Emergency healthcare spending per capita
- Travel restrictions
- Contact tracing
COVID-19 Financial Response:
- Stimulus package as a share of GDP
- Income support
- Instances of misinformation by leadership
- Limitations on press freedom, censorship
Current/Historic In-Country COVID-19 Status:
- Death rates per 1 million
- Case rates per 1 million